Athanasios Alexiou
Overview
Explore the profile of Athanasios Alexiou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
223
Citations
1564
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Almasoudi S, Al-Kuraishy H, Al-Gareeb A, Eliwa D, Alexiou A, Papadakis M, et al.
Brain Res Bull
. 2025 Mar;
224:111296.
PMID: 40073950
Alzheimer's disease (AD) is the chief cause of dementia and related mortality worldwide due to progressive accumulation of amyloid peptide (Aβ) and hyperphosphorylated tau protein. These neuropathological changes lead to...
2.
Okunlola F, Okunlola A, Adetuyi B, Soliman M, Alexiou A, Papadakis M, et al.
Clin Nutr ESPEN
. 2025 Mar;
67:71-89.
PMID: 40064239
Cardiovascular disease is one of the leading causes of death worldwide. Even while receiving adequate pharmacological treatment for their hypertension, people are nonetheless at greater risk for cardiovascular disease. There...
3.
Alsaleem M, Al-Kuraishy H, Al-Gareeb A, Abdel-Fattah M, Alrouji M, Al-Harchan N, et al.
J Cell Mol Med
. 2025 Mar;
29(5):e70378.
PMID: 40040308
Alzheimer's disease (AD) is a neurodegenerative disease caused by the progressive deposition of extracellular amyloid beta (Aβ) and intracellular neurofibrillary tangles (NFTs). Of note, metabolic disorders such as insulin resistance...
4.
Khowdiary M, Al-Kuraishy H, Al-Gareeb A, Albuhadily A, Elhenawy A, Rashwan E, et al.
Neuromolecular Med
. 2025 Mar;
27(1):20.
PMID: 40032716
Alzheimer's disease (AD) and atherosclerosis (AS) are two chronic diseases with seemingly distinct pathologies. However, emerging research points to a bidirectional relationship driven by common mechanisms, such as inflammation, oxidative...
5.
Ali N, Al-Kuraishy H, Al-Gareeb A, Alnaaim S, Alexiou A, Papadakis M, et al.
Acta Neurol Belg
. 2025 Feb;
PMID: 40021594
No abstract available.
6.
Khowdiary M, Al-Kuraishy H, Al-Gareeb A, Albuhadily A, Elhenawy A, Babalghith A, et al.
Eur J Pharmacol
. 2025 Feb;
995:177419.
PMID: 39988096
Parkinson's disease (PD) is the most common movement disorder, affecting approximately 1% of the general population over 65 years of age. PD is commonly associated with the development of motor...
7.
Iqbal U, Malik A, Sial N, Mehmood M, Uttra A, Tulain U, et al.
Food Chem Toxicol
. 2025 Feb;
199:115319.
PMID: 39965739
In order to evaluate anti-inflammatory role of eucalyptol (100, 200, and 400 mg/kg orally), inflammation was induced in rats using 0.1 ml of histamine and 0.1 ml of formaldehyde. Furthermore,...
8.
Aljarba N, Al-Kuraishy H, Al-Gareeb A, Shokr M, Papadakis M, Alexiou A, et al.
Brain Res Bull
. 2025 Feb;
222:111236.
PMID: 39892578
The advanced glycation end-products (AGEs) are toxic molecules result from non-enzymatic interactions of sugar with lipids or proteins. AGEs promote the generation of reactive oxygen species that induce the release...
9.
Mukhtar A, Mukhtar I, Muzaffar H, Faisal M, Khan K, Nawaz L, et al.
Cell Biochem Biophys
. 2025 Jan;
PMID: 39865190
Inflammatory bowel disease is a collection of intestinal disorders that cause inflammation in the digestive tract. Prolonged inflammation in the gastrointestinal tract is a major risk factor for colorectal cancer....
10.
Al-Kuraishy H, Al-Gareeb A, Zekry S, Alruwaili M, Alexiou A, Papadakis M, et al.
Neuroscience
. 2025 Jan;
568:202-208.
PMID: 39832667
Cerebrolysin (CBL) is a combination of neurotrophic peptides and amino acids derived from pig brains. CBL can cross the blood-brain barrier (BBB) and its biological effect is similar to the...